Delivery Order SPE2DR25D1100-SPE2DR26FCQ5M
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,701.65 to AmerisourceBergen Drug Corp for Corlanor 7.5 mg tablets (60-count) with an ultimate completion date of November 17, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price delivery order for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the DLA's medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $19,241.43 to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count) on November 12, 2025, with completion scheduled for November 13, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,911.92 to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 19, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed among qualified vendors in the open...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,457.28 for Corlanor 5 mg tablets (60-count) on September 2, 2025, with an ultimate completion date of September 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,197.68 to AmerisourceBergen Drug Corp for Corlanor 5 mg tablets (60-count) with a completion date of April 25, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $1,642.24 to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Corlanor 5 mg tablets (60-count) valued at $5,060.71. This firm fixed-price delivery order, with an ultimate completion date of October 24, 2025, represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with the DLA. The award was made through open competition with no set-aside designation, and performance will be executed from the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Corlanor 5 mg tablets (60-count unit) valued at $4,410.48 under a firm fixed-price contract type. This award represents a competitively awarded, non-set-aside delivery order with an ultimate completion date of September 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,199.18 to AmerisourceBergen Drug Corp for Corlanor 5 mg tablets (60-count) on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's existing federal contract portfolio with DLA. This...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $22,016.12 to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count units) with an ultimate completion date of August 21, 2025. This non-set-aside competitive award was issued on August 20, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCQ5MDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,320.68 to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count units) under a firm fixed-price contract. The award, issued on November 20, 2025, with an ultimate completion date of November 21, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Through this contract vehicle, AmerisourceBergen Drug Corp provides critical medications, vaccines, and medical supplies to federal customers including the Defense Health Agency and U.S. Coast Guard, demonstrating the company's capability to fulfill diverse and substantial federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.3k | 11/20/25 |